Basilea Pharmaceutica AG (BSLN.SW) SIX

48.40

-0.2(-0.41%)

Updated at October 21 05:19PM

Currency In CHF

Valuation

Market Cap499.91M
Enterprise Value490.88M
P/E Ratio9.27
PEG Ratio-0.51
Price/Sales Ratio3.2
Price/Book Ratio5.82
Enterprise/Revenue3.03
Enterprise/EBITDA8.51

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.35
Operating Margin0.35

Management Effectiveness

Return On Assets0.26
Return On Equity0.7

Income Statement

Revenue208.54M
Revenue/Share14.73
Gross Profit169.86M
EBITDA63.13M
Net Income77.59M
Diluted EPS5.83

Balance Sheet

Total Cash128.37M
Total Cash/Share10.27
Total Debt96.79M
Total Debt/Equity0.94
Current Ratio6.32
Book Value Per Share8.25

Price History

52-Week Change6.67
52-Week High59.7
52-Week Low37.5
Moving Average 50 Days47.81
Moving Average 200 Days46.39

Statistics

Average Volume42,791
Shares Outstanding12.27M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A